// App-Quantinova.ai

TCT-481 : A novel approach to treat de-novo coronary bifurcation lesion: results of the novel abluminal coated sirolimus eluting dedicated bifurcation stent in first 37 patients from the Bi-Siro study

Researchers

Presenter

  • Sameer Dani

Principal Investigators

  • N/A

Medical Centers

  • Lifecare Institute of Medical Sciences and Research, Ahmedabad, India

Locations

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Coronary bifurcation lesions

  • Hypertension

  • Venous thrombosis

  • Restenosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved